Trilogy Capital’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History
Bought
Maintained
Sold
Other funds holding AVEM
SC
Trilogy Capital's AVEM Position: Q2 2026 in Review
Trilogy Capital reduced its Avantis Emerging Markets Equity ETF (AVEM) stake by 3.3% in Q2 2026, selling an estimated $85.8K and leaving 27,328 shares worth $2.64M. The position accounts for 0.1% of the portfolio, ranked #145.
Trilogy Capital first reported a position in AVEM in Q3 2022 and has held it in 16 quarters since. The position peaked at $15.9M in Q3 2024. 1,005 funds tracked by Wall St. Rank hold AVEM as of Q2 2026.
- Trilogy Capital held 27,328 shares of Avantis Emerging Markets Equity ETF worth $2.64M as of Q2 2026.
- Trilogy Capital sold 930 Avantis Emerging Markets Equity ETF shares in Q2 2026, an estimated $85.8K.
- Avantis Emerging Markets Equity ETF made up 0.1% of Trilogy Capital's portfolio in Q2 2026, its #145 holding.
- Trilogy Capital first reported a position in Avantis Emerging Markets Equity ETF in Q3 2022 and has held it in 16 quarters since.
- Trilogy Capital's Avantis Emerging Markets Equity ETF position peaked at $15.9M in Q3 2024.
- 1,005 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q2 2026.
Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.